Monday, March 5, 2012

Abbott to submit Synthroid NDA.(Abbott Laboratories, new drug application)(Brief Article)

Abbott Laboratories plans to submit an NDA for Synthroid (levothyroxine sodium, USP), a treatment for hypothyroidism. The …

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)